Skip to main content
v2026.11,610 entries · CC-BY 4.0
LAC HealthLaboratory & ResearchLab & research supplies.Reagents, consumables, PPE & instruments — documented, fast, chain-of-custody shipping.Shop lac.us lac.us

Direct comparison

Grant Renewal vs. No-Cost Extension

A renewal requests new funding and re-review; a no-cost extension keeps the same budget, just more time. Eligibility, timing, and approval compared.

Side-by-side comparison

DimensionGrant Renewal (Competing Continuation)No-Cost Extension
What it requestsNew funding for a new, separate project period beyond the current award.More time on the current project period; no additional funds.
Peer review / competitionYes -- reviewed and scored like a new application (e.g. NIH Type 2 competing renewal; NSF renewal proposal under merit review).No new scientific review. Administrative approval only.
Effect on budgetNew budget for a new period; competes against other applications for available funds.Unchanged -- recipient finishes spending the existing, already-awarded budget.
Effect on project scopeCan expand or redirect aims; treated as continuing (or new) work under a fresh application.Scope must stay the same as originally approved; a scope change needs separate prior approval.
Who approves itThe funding agency, after peer/merit review -- not a unilateral institutional decision.First extension: the institution itself, under expanded authority (e.g. NIH Signing Official via eRA Commons). Second or later: the awarding agency.
Typical timingSubmitted well before the current project period ends, aligned to a standard due date or solicitation deadline.Requested near the current end date -- e.g. NIH's first extension window opens roughly 90 days before the project period ends and must be used before it ends.
Governing rule (US federal awards)Agency-specific competition rules (e.g. NIH Grants Policy Statement, NSF PAPPG); no single Uniform Guidance renewal clause.2 CFR 200.308(f) -- governs prior-approval requirements for extensions beyond the first, expanded-authority no-cost extension.
Mechanism-dependent availabilityNot every mechanism supports it -- e.g. NIH R01 allows a Type 2 competing renewal; NIH R21 does not.Generally available across mechanisms, subject to the award's own terms and the funder's expanded-authority policy.
Can be deniedYes, competitively -- can simply lose to other applications in that review round.A first extension is rarely refused if criteria are met; a second (prior-approval) extension can be denied administratively.
Can they be used togetherOften preceded by a no-cost extension that buys time to strengthen the renewal application.Commonly used as a bridge while a renewal or new competing application is prepared or under review.

Common questions

FAQ

Can I request a no-cost extension and a renewal for the same project?+

Yes, and it's a common sequence: a no-cost extension buys time to generate the additional preliminary results a competitive renewal application needs, or simply keeps a project active while a renewal application is under review. They answer different questions and can both apply to the same award at different points.

Does a no-cost extension improve my chances at a later renewal?+

Not directly -- an extension doesn't change how a renewal application is reviewed. What it can do is give a PI more time to generate the productivity, publications, or preliminary data that make a renewal application more competitive at review.

What happens if I need more money and more time?+

A no-cost extension alone won't cover a genuine budget shortfall, since it adds no funds by definition. If the remaining work needs both a longer timeline and additional money, the options are a competing renewal (if the mechanism supports one) or a new competing application, either of which can also request a longer project period than the original award.

Is a renewal the same as a "continuation"?+

No. At NIH, a "noncompeting continuation" (Type 5) is the routine, non-competed annual step within an already-awarded, multi-year project period, supported by a progress report rather than a new application -- it is not the same as a competing renewal (Type 2), which is a new, fully re-peer-reviewed application for a new project period.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →